Juan Domingo Gispert

Juan Domingo Gispert publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Juan Domingo Gispert sits on this spectrum.

Juan Domingo Gispert D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Juan Domingo Gispert sits on this spectrum.

Overview

Best Publications

• Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum.

  Andréa L Benedet;Andréa L Benedet;Marta Milà-Alomà;Agathe Vrillon;Agathe Vrillon;Nicholas J Ashton

  569
  Citations

• sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers

  Marc Suárez-Calvet;Marc Suárez-Calvet;Gernot Kleinberger;Miguel Ángel Araque Caballero;Matthias Brendel

  524
  Citations

• Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease

  Unknown

  456
  Citations

• Global and regional gray matter reductions in ADHD: A voxel-based morphometric study

  S. Carmona;O. Vilarroya;A. Bielsa;V. Trèmols

  389
  Citations

• Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected.

  Marc Suárez-Calvet;Thomas K Karikari;Nicholas J Ashton;Juan Lantero Rodríguez

  375
  Citations

• The expression of GLP‐1 receptor mRNA and protein allows the effect of GLP‐1 on glucose metabolism in the human hypothalamus and brainstem

  Elvira Alvarez;M Dolores Martínez;Isabel Roncero;Julie A Chowen

  329
  Citations

• APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease

  Unknown

  300
  Citations

• Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum

  Marta Milà-Alomà;Gemma Salvadó;Juan Domingo Gispert;Natalia Vilor-Tejedor

  231
  Citations

• The ALFA project: A research platform to identify early pathophysiological features of Alzheimer's disease.

  José Luis Molinuevo;Nina Gramunt;Juan Domingo Gispert;Karine Fauria

  190
  Citations

• Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers

  Gemma Salvadó;José Luis Molinuevo;José Luis Molinuevo;Anna Brugulat-Serrat;Carles Falcon

  189
  Citations

• Influence of the normalization template on the outcome of statistical parametric mapping of PET scans

  J.D Gispert;J Pascau;S Reig;R Martínez-Lázaro

  173
  Citations

• Ventro-striatal reductions underpin symptoms of hyperactivity and impulsivity in attention-deficit/hyperactivity disorder.

  Susanna Carmona;Erika Proal;Elseline A. Hoekzema;Juan-Domingo Gispert

  156
  Citations

• Prevalence of sleep apnoea syndrome in the Spanish adult population.

  J M Marin;J M Gascon;S Carrizo;J Gispert

  152
  Citations

• Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study.

  Núria Rodríguez de Dios;Felipe Couñago;Mauricio Murcia-Mejía;Mikel Rico-Oses

  139
  Citations

• Impact of urban environmental exposures on cognitive performance and brain structure of healthy individuals at risk for Alzheimer's dementia.

  Marta Crous-Bou;Mireia Gascon;Juan Domingo Gispert;Marta Cirach

  137
  Citations

• Effects of APOE-ε4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer's disease.

  Raffaele Cacciaglia;José Luis Molinuevo;Carles Falcón;Anna Brugulat-Serrat

  120
  Citations

• CSF Synaptic Biomarkers in the Preclinical Stage of Alzheimer Disease and Their Association With MRI and PET: A Cross-sectional Study.

  Marta Milà-Alomà;Ann Brinkmalm;Ann Brinkmalm;Nicholas J Ashton;Hlin Kvartsberg;Hlin Kvartsberg

  120
  Citations

• Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease

  Juan Domingo Gispert;Marc Suárez-Calvet;Marc Suárez-Calvet;Gemma C. Monté;Alan Tucholka

  119
  Citations

• Spatial-Temporal Patterns of β-Amyloid Accumulation

  Unknown

  104
  Citations

• Association Between Insomnia and Cognitive Performance, Gray Matter Volume, and White Matter Microstructure in Cognitively Unimpaired Adults

  Oriol Grau-Rivera;Grégory Operto;Carles Falcón;Gonzalo Sánchez-Benavides

  99
  Citations

• Method for bias field correction of brain T1-weighted magnetic resonance images minimizing segmentation error.

  Juan D. Gispert;Santiago Reig;Javier Pascau;Juan J. Vaquero

  98
  Citations

• A Personalized Preclinical Model to Evaluate the Metastatic Potential of Patient-Derived Colon Cancer Initiating Cells

  Isabel Puig;Irene Chicote;Stephan Paul Tenbaum;Oriol Arques

  92
  Citations

• Monitoring gene therapy by external imaging of mRNA: pilot study on murine erythropoietin.

  J Segura;C Fillat;D Andreu;J Llop

  86
  Citations

• A whole-brain computational modeling approach to explain the alterations in resting-state functional connectivity during progression of Alzheimer's disease

  Murat Demirtaş;Carles Falcon;Alan Tucholka;Juan Domingo Gispert

  85
  Citations

• In vivo evaluation of amyloid deposition and brain glucose metabolism of 5XFAD mice using positron emission tomography

  Santiago Rojas;José Raúl Herance;Juan Domingo Gispert;Sergio Abad

  81
  Citations

• Brain and cognitive correlates of subjective cognitive decline-plus features in a population-based cohort

  Gonzalo Sánchez-Benavides;Oriol Grau-Rivera;Marc Suárez-Calvet;Carolina Minguillon

  71
  Citations